A Phase 4, Non-treatment Follow-up For Cardiac Assessments Following Use Of Smoking Cessation Treatments In Subjects With And Without A History Of Psychiatric Disorders
A Phase 4, Non-treatment Follow-up For Cardiac Assessments Following Use Of Smoking Cessation Treatments In Subjects With And Without A History Of Psychiatric Disorders
Non-treatment extension to study A3051123, aimed at collecting data on cardiovascular safety for all participants in the A3051123 trial for an additional 28 weeks, allowing for a total of 52 weeks of cardiovascular safety data collection.
This study is an extension protocol for study A3051123. No treatment is provided during this study. This study is to monitor for cardiovascular events 28 weeks after completion of A3051123. This study is an extension protocol for study A3051123. No treatment is provided during this study. This study is to monitor for cardiovascular events 28 weeks after completion of A3051123.
Inclusion Criteria:
Exclusion Criteria:
Aurora, Colorado 80045, United States
Princeton, New Jersey 08540, United States
Capital Federal, Buenos Aires C1440BRR, Argentina
Porto Alegre, Rio Grande do Sul 90610-000, Brazil
Campinas, São Paulo 13059-740, Brazil
Moscow, 117152, Russia
Saint Petersburg, 190121, Russia
Saint Petersburg, 192019, Russia
Saint Petersburg, 197341, Russia
Benoni, Johannesburg, Gauteng 1500, South Africa